Inflation Is Rising Again. History Says These 2 Stocks Are Among the Smartest Places to Hide

Inflation has risen in 2026 compared to the previous year, primarily due to increased energy and oil prices, although it has slightly decreased over the past two months. However, the future remains uncertain, as inflation could potentially surge again if geopolitical tensions continue. Investors should be prepared for these fluctuations by considering companies that have historically performed well during periods of significant price increases.

Two such stocks to consider are Vertex Pharmaceuticals (NASDAQ: VRTX) and Visa (NYSE: V). We'll explore why these companies are worth investing in during this inflationary period.

Vertex Pharmaceuticals is a biotech leader with products in high demand, regardless of economic conditions. Unlike most of its competitors, the company has a virtual monopoly in its core therapeutic area, targeting the underlying causes of cystic fibrosis (CF). This dominance grants Vertex significant pricing power, allowing it to increase prices without losing many customers.

Although inflation may affect the company through higher costs, Vertex's pricing power enables it to offset these costs by raising prices. With consistent revenue from its CF business and an expanding portfolio, including new therapies like Casgevy and Journavx, Vertex is well-positioned to navigate this inflationary period and deliver strong returns over the long run.